OTCMKTS:SNYNF Sanofi (SNYNF) Stock Price, News & Analysis $96.45 0.00 (0.00%) As of 11/17/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartFDA EventsFinancialsNews and TrendsSEC Filings About Sanofi Stock (OTCMKTS:SNYNF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sanofi alerts:Sign Up Key Stats Today's Range$96.45▼$96.4550-Day Range$76.76▼$96.8152-Week Range$76.76▼$106.34Volume33 shsAverage Volume24,707 shsMarket CapitalizationN/AP/E Ratio31.27Dividend Yield2.90%Price TargetN/AConsensus RatingN/A Company Overview Sanofi is a France-based global healthcare company focused on the research, development, manufacturing and commercialization of pharmaceutical products and vaccines. Its portfolio includes medicines for immunology, rare diseases, neurology, oncology and other specialty-care areas, as well as treatments for common conditions such as diabetes and cardiovascular disease. The company’s well-known products include Dupixent, an immunology medicine developed with Regeneron; vaccines marketed through its Vaccines division, including influenza and travel vaccines; and established prescription medicines in several therapeutic categories. Sanofi also develops biologic medicines and other innovative therapies for patients with chronic, debilitating or rare conditions. Sanofi serves patients and healthcare providers in markets around the world through research, manufacturing and commercial operations across North America, Europe, Asia and other international regions. The company was created in its current form through the 2004 merger of Sanofi-Synthélabo and Aventis, combining the businesses of two major French pharmaceutical groups. Its global headquarters are in Paris, France, and Paul Hudson has served as chief executive officer since 2019.AI Generated. May Contain Errors. Read More Receive SNYNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SNYNF Stock News HeadlinesAnalysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Amgen (AMGN)November 6, 2026 | theglobeandmail.comBernstein Sticks to Their Buy Rating for Sanofi (SNYNF)November 5, 2026 | theglobeandmail.comYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strategy guide, titled How To Turn $100 Options Into $1,000 Gains, before it moves behind a paywall. The guide walks through options trading concepts the team uses in its own research and education materials. Once the paywall goes up, free access ends for good.November 18 at 1:00 AM | TradeWins (Ad)Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX) and Sanofi (OtherSNYNF)November 5, 2026 | theglobeandmail.comAnalysts Conflicted on These Healthcare Names: Sanofi (OtherSNYNF) and Resmed (RMD)November 2, 2026 | theglobeandmail.combiotech daily doseOctober 31, 2026 | rttnews.comJ.P. Morgan Sticks to Their Hold Rating for Sanofi (SNYNF)October 31, 2026 | theglobeandmail.comSanofi Q3 Net Profit, Business Profit Climb; Lifts FY26 OutlookOctober 30, 2026 | rttnews.comSee More Headlines SNYNF Stock Analysis - Frequently Asked Questions How have SNYNF shares performed this year? Sanofi's stock was trading at $97.2950 at the start of the year. Since then, SNYNF stock has decreased by 0.9% and is now trading at $96.45. How do I buy shares of Sanofi? Shares of SNYNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today11/18/2026Next Earnings (Estimated)1/28/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:SNYNF CIK1121404 Webwww.sanofi.com Phone(315) 377-4000FaxN/AEmployees76,493Year Founded2004Profitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio31.27 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (OTCMKTS:SNYNF) was last updated on 11/17/2026 by MarketBeat.com Staff. From Our PartnersPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredGet your evenings backThe Instant Scanner delivers the night's qualifying setups with exact buy prices and defined exits, in minutes...Profits Run | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredIntel Shares Jumped 177% After Elon Musk's DealElon Musk's April 2026 partnership with Intel sent shares climbing 177% within two months. Jeff Brown, the ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.